[Acute response of right ventricular function to iloprost inhalations in patients with pulmonary arterial hypertension: preliminary evaluation with cardiac magnetic resonance imaging]
- PMID: 25800574
- PMCID: PMC6000010
- DOI: 10.3779/j.issn.1009-3419.2015.03.07
[Acute response of right ventricular function to iloprost inhalations in patients with pulmonary arterial hypertension: preliminary evaluation with cardiac magnetic resonance imaging]
Abstract
Background: Pulmonary arterial hypertension (PAH) is a progressive disorder characterized by abnormally elevated blood pressure of the pulmonary circulation. Without treatment, PAH progresses rapidly to right ventricular (RV) failure and even death. Cardiac magnetic resonance imaging (CMRI) has been an accurate and reproducible tool to assessment of RV morphology and function, which are important factors in the prognosis of patients with PAH. The aim of this study is to investigate acute RV response to inhalation of aerosolized iloprost in patients with PAH using CMRI.
Methods: From March 2012 to March 2014, 48 patients with PAH underwent CMRI before and immediately after inhalation of iloprost with a single dose of 20 μg over 15 min-20 min. RV function parameters derived from CMRI images were analyzed before and after iloprost inhalation, including end-diastolic volume (EDV), end-diastolic area (EDA), end-systolic volume (ESV), end-systolic area (ESA), stroke volume (SV), ejection fraction (EF) and cardiac output (CO). Percentage of RV area change was also calculated [%RVAC=(EDA-ESA)/EDA×100%]. Wilcoxon's Sign Rank Test or Paired Samples t-Test was used to compare the differences of RV function parameters before and after inhalation.
Results: After iloprost inhalation, all patients showed significant decrease in RV EDV and RV ESV (P=0.007, P<0.001 respectively). Whereas, there were significant increase in RV SV (P=0.014), RV EF (P=0.009) and %RVAC (P=0.006). RV CO had no significant difference before and after inhalation (P=0.851).
Conclusions: Inhalation of iloprost can immediately improve RV function in patients with PAH, and noninvasive evaluation of the acute response with CMRI is feasibility.
背景与目的 肺动脉高压(pulmonary arterial hypertension, PAH)是以肺循环压力异常增高为特征的进展性疾病,可引起右心室(right ventricle, RV)功能进行性衰竭,最终导致死亡。因此RV功能的评估在PAH的诊断、随访中起着重要作用。心脏磁共振成像(cardiac magnetic resonance imaging, CMRI)成为无创评价心室功能的参照标准,尤其是RV功能。本研究通过CMRI评估吸入伊洛前列素对PAH患者RV功能影响的即刻效应。方法 2012年3月-2014年3月PAH患者48例,吸入单剂量20 μg的伊洛前列素溶液前、后立即进行CMRI检查,测量RV的舒张末期容积(end-diastolic volume, EDV)、收缩末期容积(end-systolic volume, ESV)、每搏输出量(stroke volume, SV)、射血分数(ejection fraction, EF)、心输出量(cardiac output, CO)、舒张末期面积(end-diastolic area, EDA)及收缩末期面积(end-systolic area, ESA)。RV面积变化百分比(percentage of RV area change, %RVAC)由公式[%RVAC=(EDA-ESA)/EDA×100%]计算获得。采用Wilcoxon符号秩和检验或配对t检验分析吸入伊洛前列素前、后RV功能参数变化。P<0.05为差异有统计学意义。结果 吸入伊洛前列素后,患者的RV功能改善,RV EDV、RV ESV显著下降(P=0.007, P<0.001),RV SV、RV EF及%RVAC增加(P=0.014, P=0.009, P=0.006),RV CO无变化(P=0.851)。结论 吸入伊洛前列素能立即明显改善PAH患者的RV功能,CMRI能准确、无创地评估该即刻效应。.
Figures


Similar articles
-
Three-dimensional modeling of the right ventricle from two-dimensional transthoracic echocardiographic images: utility of knowledge-based reconstruction in pulmonary arterial hypertension.J Am Soc Echocardiogr. 2013 Aug;26(8):860-7. doi: 10.1016/j.echo.2013.05.007. Epub 2013 Jun 13. J Am Soc Echocardiogr. 2013. PMID: 23768691
-
Imaging right ventricular function to predict outcome in pulmonary arterial hypertension.Int J Cardiol. 2016 Sep 1;218:206-211. doi: 10.1016/j.ijcard.2016.05.015. Epub 2016 May 13. Int J Cardiol. 2016. PMID: 27236116 Free PMC article.
-
[Assessing right ventricular function in patients with pulmonary artery hypertension based on noninvasive measurements: correlation between cardiac MRI, ultrasonic cardiogram, multidetector CT and right heart catheterization].Zhonghua Yi Xue Za Zhi. 2018 Nov 20;98(43):3528-3531. doi: 10.3760/cma.j.issn.0376-2491.2018.43.013. Zhonghua Yi Xue Za Zhi. 2018. PMID: 30481904 Chinese.
-
Cardiac magnetic resonance imaging in pulmonary arterial hypertension.Eur Respir Rev. 2013 Dec;22(130):526-34. doi: 10.1183/09059180.00006313. Eur Respir Rev. 2013. PMID: 24293468 Free PMC article. Review.
-
Cardiac magnetic resonance imaging: what can it add to our knowledge of the right ventricle in pulmonary arterial hypertension?Am J Cardiol. 2012 Sep 15;110(6 Suppl):25S-31S. doi: 10.1016/j.amjcard.2012.06.013. Am J Cardiol. 2012. PMID: 22921028 Review.
Cited by
-
[Measurements of Pulmonary Artery Size for Assessment of Pulmonary Hypertension by Cardiovascular Magnetic Resonance and Clinical Application].Zhongguo Fei Ai Za Zhi. 2017 Feb 20;20(2):93-99. doi: 10.3779/j.issn.1009-3419.2017.02.10. Zhongguo Fei Ai Za Zhi. 2017. PMID: 28228220 Free PMC article. Chinese.
-
[Evaluation of Pulmonary Hypertension with CMR: Pulmonary Hypertension Patients and Healthy Volunteers Control Study].Zhongguo Fei Ai Za Zhi. 2016 May 20;19(5):293-8. doi: 10.3779/j.issn.1009-3419.2016.05.07. Zhongguo Fei Ai Za Zhi. 2016. PMID: 27215458 Free PMC article. Chinese.
References
-
- Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. http://www.sciencedirect.com/science/article/pii/S0735109713058750. J Am Coll Cardiol. 2013;62(25 Suppl):D42–D50. - PubMed
-
- Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34–D41. - PubMed
-
- Han Y, Yang ZW, Yu TL, et al. The assessment of right ventricular function and pulmonary artery hemodynamics in patients with pulmonary hypertension by 1.5 T MRI. Zhongguo Fei Ai Za Zhi. 2012;15(8):471–475. - PMC - PubMed
- 韩 艳, 杨 振文, 于 铁链, et al. 1.5T MRI评估肺动脉高压患者右心功能及肺动脉血液动力学. 中国肺癌杂志. 2012;15(8):471–475. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical